Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00338884
Status:
COMPLETED
Last Update Posted:
2012-08-31
First Post:
2006-06-16
Brief Title:
Safety And Effectiveness Of Daily Dosing With 375 mg Sunitinib Malate In Patients With Advanced Kidney Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Carcinoma Renal Cell |
Keywords: